Matches in Wikidata for { <http://www.wikidata.org/entity/Q98906615> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q98906615 description "2020 സപ്തംബര് 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q98906615 description "article scientifique publié en 2020" @default.
- Q98906615 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q98906615 description "scientific article published on 01 September 2020" @default.
- Q98906615 description "wetenschappelijk artikel" @default.
- Q98906615 description "наукова стаття, опублікована 1 вересня 2020" @default.
- Q98906615 name "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 name "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 type Item @default.
- Q98906615 label "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 label "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 prefLabel "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 prefLabel "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 P1433 Q98906615-16AF6B64-A717-4065-8952-712C9678D8D5 @default.
- Q98906615 P1476 Q98906615-A76E9525-1A0A-4A36-82C6-D2B850D66A25 @default.
- Q98906615 P2093 Q98906615-296E72D0-96AF-431E-9B27-8F7E6FA8E92C @default.
- Q98906615 P2093 Q98906615-3537FC23-ABE4-4626-B599-D8E328C198A8 @default.
- Q98906615 P2093 Q98906615-59CF4B8D-3D96-4899-AE2F-4B12CD487173 @default.
- Q98906615 P2093 Q98906615-969C0785-3A6B-4843-91EC-2BA476B7B867 @default.
- Q98906615 P2093 Q98906615-A8339AFA-685B-46B9-AD4B-F4E89E53F4C2 @default.
- Q98906615 P2093 Q98906615-AD1C4752-69ED-4623-9818-3D0106407915 @default.
- Q98906615 P2093 Q98906615-AE8C49E2-649E-4E86-AA49-2D53AC4213D5 @default.
- Q98906615 P2093 Q98906615-E781E08A-9C78-41D6-B744-04B3710CC6A3 @default.
- Q98906615 P304 Q98906615-845F8931-2849-4156-9C93-324C3C6334E6 @default.
- Q98906615 P31 Q98906615-781CF95C-F7D5-4286-94BA-91F3A91B85EE @default.
- Q98906615 P433 Q98906615-80B81BBF-FAD5-43CF-B6DA-4472837ADB65 @default.
- Q98906615 P478 Q98906615-CDBDD297-F18D-4997-9FE2-E4B813CC2F23 @default.
- Q98906615 P577 Q98906615-7C00C1E8-7619-4F70-967C-180C564C38D4 @default.
- Q98906615 P698 Q98906615-951BA8DD-2AA6-4A53-ADDB-3AAEA1262BC3 @default.
- Q98906615 P698 32879267 @default.
- Q98906615 P1433 Q27711825 @default.
- Q98906615 P1476 "[Effects of Olmesartan Medoxomil on Patients with Thoracic and Thoracoabdominal Aortic Aneurysm;Evaluation of Anti-hypertensive Effect and Possible Suppression of Aneurysmal Dilation( OLM 40 Study)]" @default.
- Q98906615 P2093 "Kiichiro Kumagai" @default.
- Q98906615 P2093 "Konosuke Sasaki" @default.
- Q98906615 P2093 "Masatoshi Akiyama" @default.
- Q98906615 P2093 "Mitsuru Sato" @default.
- Q98906615 P2093 "Naotaka Motoyoshi" @default.
- Q98906615 P2093 "Osamu Adachi" @default.
- Q98906615 P2093 "Yoshikatsu Saiki" @default.
- Q98906615 P2093 "Yumi Sugawara" @default.
- Q98906615 P304 "652-661" @default.
- Q98906615 P31 Q13442814 @default.
- Q98906615 P433 "9" @default.
- Q98906615 P478 "73" @default.
- Q98906615 P577 "2020-09-01T00:00:00Z" @default.
- Q98906615 P698 "32879267" @default.